ERIS Lifesciences Ltd

About [ edit ]

ERIS Lifesciences is engaged in the business of manufacture and marketing of pharmaceutical products.

  • Market Cap 8,069 Cr.
  • Current Price 594
  • High / Low 643 / 321
  • Stock P/E 23.5
  • Book Value 104
  • Dividend Yield 0.93 %
  • ROCE 25.0 %
  • ROE 23.9 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.66%

Cons

  • Tax rate seems low
  • Debtor days have increased from 37.65 to 53.31 days.
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
212 251 264 252 215 274 285 266 249 293 330 310
140 162 163 159 153 170 175 190 171 189 205 203
Operating Profit 72 89 101 94 62 105 110 77 77 104 125 107
OPM % 34% 35% 38% 37% 29% 38% 39% 29% 31% 35% 38% 35%
Other Income 7 4 6 10 12 3 5 8 -1 1 2 3
Interest 8 7 6 5 4 1 1 0 0 0 0 0
Depreciation 9 7 8 10 11 12 12 13 14 10 11 11
Profit before tax 62 78 92 89 58 95 103 72 62 95 116 99
Tax % 10% 8% 7% 10% 7% 11% 10% 12% 9% 6% 7% 9%
Net Profit 56 71 85 80 54 84 93 63 56 89 108 90
EPS in Rs 4.08 5.18 6.20 5.83 3.93 6.11 6.74 4.62 4.13 6.56 7.93 6.64
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
274 393 509 546 597 750 856 982 1,074 1,182
215 307 410 424 425 480 533 637 706 769
Operating Profit 59 86 99 121 172 269 322 345 369 413
OPM % 21% 22% 19% 22% 29% 36% 38% 35% 34% 35%
Other Income 1 1 4 3 3 25 26 32 15 6
Interest 1 1 0 0 0 1 11 23 2 2
Depreciation 3 3 5 16 20 23 26 36 50 46
Profit before tax 55 83 98 109 154 270 312 317 331 371
Tax % 33% 30% 28% 18% 13% 9% 6% 8% 11%
Net Profit 37 58 70 89 134 247 294 291 296 343
EPS in Rs 2,686.55 4,232.73 5,121.45 6,489.45 9,714.18 17.95 21.39 21.15 21.84 25.26
Dividend Payout % -0% -0% -0% -0% 63% -0% -0% -0% 13%
Compounded Sales Growth
10 Years:%
5 Years:15%
3 Years:13%
TTM:14%
Compounded Profit Growth
10 Years:%
5 Years:28%
3 Years:6%
TTM:17%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-8%
1 Year:37%
Return on Equity
10 Years:%
5 Years:34%
3 Years:30%
Last Year:24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
0 0 0 0 0 14 14 14 14 14
Reserves 48 106 176 266 299 553 848 1,137 1,283 1,404
Borrowings 5 3 1 1 0 1 377 176 -0 9
49 63 94 91 98 124 170 175 205 258
Total Liabilities 102 172 271 357 397 692 1,408 1,502 1,502 1,685
23 27 75 72 71 232 771 761 875 862
CWIP -0 -0 -0 -0 -0 0 -0 3 4 -0
Investments 13 47 84 167 190 303 365 356 78 139
65 98 112 119 136 157 271 383 544 683
Total Assets 102 172 271 357 397 692 1,408 1,502 1,502 1,685

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
30 38 90 90 131 200 235 223 271
-19 -36 -83 -92 -44 -184 -590 -5 123
-10 -3 -2 0 -84 -24 363 -221 -335
Net Cash Flow 1 -1 5 -2 4 -8 8 -3 60

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 104% 66% 48% 54% 62% 35% 26% 25%
Debtor Days 19 15 16 16 16 24 28 31 53
Inventory Turnover 2.28 2.27 1.94 1.93 2.08 2.26 2.12 2.32

Shareholding Pattern

Numbers in percentages

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
55.93 55.93 55.92 56.04 56.10 56.23 56.23 56.23 55.55 55.55 54.08 54.23
8.59 8.68 8.65 8.42 8.14 7.92 6.06 8.85 10.19 10.11 11.13 11.30
10.82 10.79 11.16 11.35 11.65 11.72 13.44 11.81 11.18 11.33 10.90 10.26
24.66 24.60 24.26 24.19 24.11 24.13 24.27 23.11 23.08 23.01 23.89 24.22

Documents

Add document